PURPOSE: To examine the relation of visual function to retinal nerve fiber layer (RNFL)
thickness as a structural biomarker for axonal loss in multiple sclerosis (MS), and to compare …

We evaluated the safety, tolerability, pharmacodynamics, and activity of B‐cell depletion with
rituximab in patients with relapsing‐remitting multiple sclerosis, receiving two courses of …

Objective Cross‐sectional studies of optical coherence tomography (OCT) show that retinal
nerve fiber layer (RNFL) thickness is reduced in multiple sclerosis (MS) and correlates with …

Background Inner (area adjacent to the fovea) and outer regions of the macula differ with
respect to relative thicknesses of the ganglion cell layer (neurons) vs retinal nerve fiber layer (…

In patients with multiple sclerosis (MS), activation of immune cells and breakdown of the
blood–brain barrier (BBB) lead to demyelination and axon injury. Although repairing damage to …

Background Optical coherence tomography (OCT) and scanning laser polarimetry with
variable corneal compensation (GDx) are similar yet provide information on different aspects of …

Objective: To examine the relation between low contrast letter acuity, a new visual function
test for multiple sclerosis (MS) trials, and vision targeted health related quality of life (HRQOL)…

White matter of the brain has been demonstrated to have multiple relaxation components.
Among them, the short transverse relaxation time component (T 2 < 40 ms; T 2 ⁎ < 25 ms at 3 T…

PURPOSE: To determine whether a 10-Item Neuro-Ophthalmic Supplement increases the
capacity of the 25-Item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) to …

Objective: The objective of this study is to evaluate the safety and tolerability of inosine in
patients with relapsing–remitting multiple sclerosis (RRMS). The secondary objectives are to …